aTyr Pharma, Inc.

( )
LIFE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -6.02%384.210.0%$5285.71m
BNTXBioNTech SE -9.96%276.520.0%$899.27m
NVAXNovavax, Inc. -11.34%204.8379.4%$857.11m
SNSSSunesis Pharmaceuticals, Inc. -5.26%7.930.7%$554.34m
AMGNAmgen, Inc. -0.39%212.271.4%$540.36m
GILDGilead Sciences, Inc. -0.63%69.971.0%$446.95m
REGNRegeneron Pharmaceuticals, Inc. -2.27%605.002.7%$428.21m
ILMNIllumina, Inc. -3.61%410.203.5%$346.87m
BIIBBiogen, Inc. -0.67%284.711.7%$303.41m
VRTXVertex Pharmaceuticals, Inc. -0.99%181.601.9%$247.39m
ISEEIVERIC bio, Inc. -10.97%15.580.0%$187.66m
LIFEaTyr Pharma, Inc. -1.41%9.762.1%$149.96m
BGNEBeiGene Ltd. -3.55%363.801.3%$141.01m
TECHBio-Techne Corp. -4.42%488.874.5%$131.91m
KDMNKadmon Holdings, Inc. -0.45%8.800.8%$129.86m

Company Profile

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways. Its product pipeline include ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1;DARS-1(3). The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.